Understanding Meningioma and Health Factors

This study is looking at how different health factors, including social and structural determinants of health (things like your living situation or access to healthcare), and individual risk factors might affect people with meningioma (the most common type of brain tumor). Researchers want to understand why some groups of people with meningioma have more severe tumors and worse health outcomes. You can join if you are an adult (18 or older) who can read and speak English and have been diagnosed with meningioma. The study involves completing a questionnaire and allowing researchers to review your medical records. The main goal is to identify and understand the distribution of these health factors and any differences among people with meningioma over a period of up to five years. The current recruitment status is unclear.

Study design
This is an observational study planning to enroll 3000 participants. It is not testing a new treatment, but rather observing information about people with meningioma.
What's involved
You would complete a questionnaire, either in person or online, and allow researchers to review your medical records.
Compensation
Not stated in the trial record.
Follow-up
The study will look at information for up to five years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07418775

Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma

Recruiting
Not specifiedAges 18+Observational
University of California, San Francisco
~3,000 participants
Updated 2026-05-19 on ClinicalTrials.gov
What's tested:QuestionnaireMedical Record Review

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Identifying potential social and structural determinants of health (SSDH)
Measured over Up to 5 years
+2 more outcomes measured
Meningioma of Brain
Meningioma
Brain Tumor
1 sites across 1 states
California1
  • David Raleigh, MD, PhD · PRINCIPAL_INVESTIGATOR · University of California, San Francisco, San Francisco, California 94143

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adults ≥18 years of age
Able to speak and read English
Diagnosed with a meningioma

Exclusion

Active psychiatric issues (suicidality, active psychosis, grave disability, etc.)
Inability to consent secondary to severe neurologic deficit or psychiatric distress
Inability to complete survey secondary to severe neurologic deficit or psychiatric distress
  • Identifying potential social and structural determinants of health (SSDH)Up to 5 years

    The prevalence of SSDH factors such as race and ethnicity, birthplace, relationship status, sexual orientation/gender identity, education level, socio-economic status, access to care, reproductive/menstrual history, health factors and medication use, chemical and radiation exposure, smoking history, and perceived stress for participants with meningioma will be analyzed using multilevel logistic and linear models accounting for geographical clustering.

  • Distribution of social and structural determinants of healthUp to 5 years

    The distribution of SSDH factors across racial groups will be analyzed using multilevel logistic and linear models accounting for geographical clustering.

  • Identify disparities in social and structural determinants of health (SSDH)Up to 5 years

    Disparities of SSDH factors across racial groups will be analyzed using multilevel logistic and linear models accounting for geographical clustering.